Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weight-based enoxaparin for VTE prevention in morbidly obese patients
NCT00585182Phase 4Completed
- Sponsor
- University of Utah
- Start
- Jan 2007
- Primary completion
- Apr 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of enoxaparin in venous thromboembolism (VTE), sponsored by University of Utah. Started Jan 2007; status: completed.
02
Drugs
enoxaparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00585182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00585182.